AI-driven genetic medicines platform
Deep Genomics (deepgenomics.com) earns a Brand Analyzer score of 70 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Deep Genomics ranks in the 62nd percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 88/100, Digital Presence 82/100, Visual Identity 94/100, Messaging Clarity 95/100, Trust Foundation 60/100, AI Discoverability 74/100, Brand Authority 28/100.
Deep Genomics is a healthcare and technology company positioned at the forefront of AI-driven genetic medicine. It operates as a platform company that combines artificial intelligence, biology, and automation to address molecular design and target biology challenges. The company aims to eliminate slow, empirical iteration in genetic medicine development by building a world-class technology platform, collaborating across disciplines to advance a new approach to medicine.
| Brand Name | Deep Genomics |
|---|---|
| Domain | deepgenomics.com |
| Industry | Healthcare, Technology |
| Main Competitors | Recursion Pharmaceuticals, Insitro, Exscientia, BioNTech, Relay Therapeutics, Insilico Medicine |
Moz Domain Authority 47/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,356,032 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Microdata (Schema.org), og:title, og:description, og:image, og:type, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, GitHub; no detected presence on X (Twitter), Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Deep Genomics scores 30/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Deep Genomics has a weak AI-visibility profile at 30/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (55/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,356,032 (Tranco) and a Moz Domain Authority of 47/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Deep Genomics's main competitors include Recursion Pharmaceuticals, Insitro, Exscientia, BioNTech, Relay Therapeutics. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Deep Genomics official site
Popular alternatives to Deep Genomics include Recursion Pharmaceuticals, Insitro, Exscientia, BioNTech, Relay Therapeutics. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Deep Genomics official site
Deep Genomics has limited AI-search visibility, scoring 30/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 33, recommendation 55). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Deep Genomics official site
Deep Genomics and Recursion Pharmaceuticals are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Deep Genomics official site
Deep Genomics scores 55/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Deep Genomics official site
Deep Genomics is a healthcare and technology company that operates at the forefront of AI-driven genetic medicine. It functions as a platform company, integrating revolutions in artificial intelligence, biology, and automation to pioneer a new approach to medicine. The company is focused on solving hard molecular design and target biology problems through collaborative, cross-disciplinary work underpinned by advanced AI technologies.
Sources: Deep Genomics official site
Deep Genomics collaborates across scientific disciplines to solve molecular design and target biology problems using artificial intelligence. It builds a world-class technology platform designed to eliminate slow, empirical iteration in the development of genetic medicines. By combining AI, biology, and automation, the company works to accelerate and improve the process of discovering and developing genetic medicine candidates.
Sources: Deep Genomics official site
Deep Genomics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Deep Genomics official site
Deep Genomics is known for being at the forefront of AI-driven genetic medicine. It is recognized as a platform company that applies artificial intelligence alongside advances in biology and automation to transform the development of genetic medicines. Its approach focuses on removing the slow, iterative empirical processes traditionally associated with genetic medicine development.
Sources: Deep Genomics official site
Deep Genomics targets researchers, scientists, and professionals working in genetic medicine and biotechnology. Its platform and collaborative approach are oriented toward those who are inspired to innovate within these fields, including cross-disciplinary teams seeking to apply AI to solve complex molecular design and target biology problems in the development of genetic medicines.
Sources: Deep Genomics official site
Ranked closest to Deep Genomics: Cydar Medical (70/100), CXT Software (70/100), EnlivenHealth (70/100), E-vet Software (70/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).